Clinical Report: Autologous Fat Transfer for Complex Anal Fistulas

Overview

Autologous fat grafting (AFG) shows promise as a treatment for complex anal fistulas, including those associated with Crohn’s disease. This retrospective review demonstrates favorable healing rates and safety profiles comparable to more costly stem cell therapies.

Background

Anal fistulas affect 20,000 to 25,000 new patients annually in the USA, with a high risk of development following perianal abscess drainage and in Crohn’s disease (CD) patients. Current treatments combining antibiotics, biologics, immunosuppressants, and surgery often result in high recurrence and nonhealing rates, especially in CD. Autologous fat grafting, containing adipose-derived stem cells, has been effective in improving healing in complex wounds and is hypothesized to offer a safe, cost-effective alternative for fistula treatment.

Data Highlights

The study retrospectively reviewed patients treated with AFG from 2016 to 2021, analyzing demographics, procedural details, and clinical outcomes such as symptom improvement, fistula closure, recurrence, and fecal incontinence. Subgroup analyses evaluated differences based on IBD status, number of procedures, fat processing method, diversion, and internal orifice management. Clinical closure was defined by resolution of drainage, pain, and fistula orifice closure, while recurrence was defined as persistence or symptom return within 3 months.

Key Findings

• AFG was used successfully in both Crohn’s and non-Crohn’s anal fistulas, often after failure of standard surgical treatments.
• Clinical closure was achieved by resolution of drainage, pain, and fistula orifice closure on exam.
• Recurrence was defined as fistula persistence or symptom return within 3 months, with rates analyzed accordingly.
• Lipoaspirate was harvested from multiple donor sites when necessary and processed either by simple gravity separation or with the REVOLVE system, based on surgeon preference.
• The internal fistula opening was closed with absorbable sutures, and fat grafts were injected carefully around the internal orifice and tract to avoid complications such as abscess formation.
• Postoperative care included wound management, a 1-week course of oral antibiotics, and stool softeners as needed.

Clinical Implications

AFG offers a minimally invasive, safe, and potentially cost-effective treatment option for complex anal fistulas, including those related to Crohn’s disease. Its use may reduce the need for multiple surgeries and improve healing outcomes while minimizing risks such as incontinence. Careful technique in fat harvest, processing, and injection is critical to optimize results and avoid complications.

Conclusion

Autologous fat transfer represents a promising approach for treating complex anal fistulas, demonstrating healing outcomes comparable to advanced stem cell therapies with a favorable safety profile. Further prospective studies may solidify its role in fistula management, particularly in challenging Crohn’s disease cases.

References

1. Multiple sources cited within article (2013–2021) -- Autologous Fat Transfer: A Promising Approach for Treating Complex Anal Fistulas